Aadi Bioscience Earnings Preview
Portfolio Pulse from Benzinga Insights
Aadi Bioscience (NASDAQ:AADI) is scheduled to release its quarterly earnings report on March 13, 2024, with analysts expecting an EPS of $-0.65. The company's past earnings performance shows a mixed impact on its stock price, with the last quarter beating EPS estimates but resulting in a 3.23% drop in share price the following day. Over the last year, AADI shares have declined by 75.62%, indicating a bearish sentiment among long-term shareholders.
March 12, 2024 | 5:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Aadi Bioscience is expected to report an EPS of $-0.65 for the upcoming quarter. Historical data shows fluctuating stock price reactions to earnings reports, with a significant 75.62% decline over the past year.
Given the expected EPS and Aadi Bioscience's historical performance, there's a cautious outlook for the short term. The past year's significant decline in share price and mixed reactions to earnings reports suggest a potential negative impact on the stock price following the earnings announcement.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100